Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Lancet Infectious Diseases

Volumn 2, Issue 8, 2002, Pages 487-493

  Velasco Hernandez, J X ^a   Gershengorn, H B ^b   Blower, S M ^c  

^a INSTITUTO MEXICANO DEL PETRÓLEO   (Mexico)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

DISEASE SEVERITY; DRUG USE; EPIDEMIC; ERADICATION THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; REVIEW; SEXUAL BEHAVIOR; UNITED STATES; VIRUS TRANSMISSION;

EID: 0036327914     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00346-8     Document Type: Review

References (41)

1. Control strategies for tuberculosis epidemics: New models for old problems
2. Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: A theoretical framework
3. Global elimination of trachoma: How frequently should we administer mass chemotherapy?
4. Live attenuated HIV vaccines: Predicting the trade-off between efficacy and safety
5. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
6. HIV-1 drug resistance in newly infected individuals
7. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
8. Transmission of antiretroviral drug-resistant HIV-1 variants
9. Prevalence of HIV 1 resistant antiretroviral drugs in 81 individuals newly infected by sexual contact or IDU
10. A tale of two futures: HIV and antiretroviral therapy in San Francisco
11. Predicting the unpredictable: Transmission of drug-resistant HIV
12. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations
13. Prophylactic vaccines, risk behavior change and the probability of eradicating HIV in San Francisco
14. U.S. priorities - HIV prevention
15. Sensitivity and uncertainty analysis of complex models of disease transmission: An HIV model, as an example
16. Predicting and preventing the emergence of antiviral drug resistance in HSV-2
17. An approach to sensitivity analysis of computer models, part 1. Introduction, input variable selection and preliminary variable assessment
18. An approach to sensitivity analysis of computer models, part 2. Ranking of input variables, response surface validation, distribution effect and techniques synopsis
19. The intrinsic transmission dynamics of tuberculosis epidemics
20. Uncertainty and sensitivity analysis of the basic reproductive rate: Tuberculosis as an example
21. The impact of antivirals and the emergence of drug resistance: HSV-2 epidemic control
22. Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy
23. Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patients
24. Strategies for long-term success in the treatment of HIV infection
25. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
26. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients
27. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
28. Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases
29. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA study
30. An investigation of uncertainty and sensitivity analysis techniques for computer models
31. Statistical analyses of scatter plots to identify important factors in large-scale simulations, 1: Review and comparison of techniques
32. Viral load and heterosexual transmission of human immunodeficiency virus type 1
33. Modelling the effect of treatment and behavioral change in HIV transmission dynamics
34. Community treatment of HIV-1: Initial stage and asymptotic dynamics
35. Increases in unsafe sex and rectal gonorrhoea among men who have sex with men - San Francisco, California, 1994-1997
36. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco
37. Cost-effectiveness of HIV/AIDS interventions in Africa: A systematic review of the evidence
38. HIV prevention before HAART in sub-Saharan Africa